Santhera Pharmaceuticals Holding's market cap is currently $140.58M. The company's EPS TTM is CHF-3.04; its P/E ratio is 2.58; Santhera Pharmaceuticals Holding is scheduled to report earnings on September 23, 2025, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CHF
Santhera Pharmaceuticals Holding Earnings and Revenue History
